|
Neonatal Intensive Care Drug Manual
|
| bet | 139/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Cyclomydril
Revision Date : 15-12-2020
|
Approved: TC, KOH
|
Alert
|
Unapproved medicine in Australia and New Zealand. Available only through Special Access Scheme Category C Pathway.
For topical ophthalmic use only.
|
Indication
|
Mydriatic (dilates the pupil) and cycloplegic (prevents accommodation of the eye) for ophthalmic examinations and therapeutic procedures
|
Action
|
Contains cyclopentolate hydrochloride 0.2% and phenylephrine hydrochloride 1%. Cyclopentolate hydrochloride is an anticholinergic drug and phenylephrine hydrochloride is an adrenergic drug. This combination induces mydriasis that is greater than that of either drug alone at its respective concentration. The concentrations of cyclopentolate and phenylephrine have been selected to induce mydriasis with little accompanying cycloplegia.
|
Drug type
|
Antimuscarinic (cyclopentolate) and sympathomimetic (phenylephrine).
|
|
|
| |
